This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Jagotec Ag. Active years: 2012-2018.
Company Filing History:
Years Active: 2012-2018
Title: The Innovative Contributions of Christophe Dragan
Introduction
Christophe Dragan is an accomplished inventor based in Geispitzen, France, known for his significant contributions to the field of pharmaceutical formulations. With six patents to his name, Dragan has made remarkable strides in creating innovative drug delivery systems that enhance the effectiveness and efficiency of medications.
Latest Patents
Among his latest innovations is a groundbreaking delayed release tablet with a defined core geometry. This invention features a tablet that consists of a core containing an active agent, which is encased in a coating. Notably, the core is positioned within the coating in such a way that the coating has a thickness of approximately 4.85 to 4.95 mm along the longitudinal axis (X-Y). This unique configuration allows for the rapid release of the active agent following a predetermined lag time during which no active agent is released. This innovation is poised to redefine how certain medications are administered, offering enhanced patient outcomes.
Career Highlights
Christophe Dragan’s career has been marked by a committed focus on the development of innovative pharmaceutical solutions. His work at Jagotec Ag has positioned him at the forefront of drug delivery research, enabling him to pioneer developments that have the potential to transform treatment approaches in various medical fields.
Collaborations
Throughout his career, Dragan has collaborated with esteemed colleagues such as Guy Vergnault and Pascal Grenier. These partnerships have fostered a dynamic environment for innovation at Jagotec Ag, facilitating the exchange of ideas and expertise critical to the development of effective drug delivery systems.
Conclusion
Christophe Dragan continues to be a pivotal figure in the innovation landscape, driving advancements in the pharmaceutical industry with his inventive spirit and dedication to improving patient care. His latest patents exemplify the potential for future breakthroughs that could redefine how medications are delivered and consumed globally. As he progresses in his career, the impact of his work will likely resonate through the medical community and beyond.